{
  "meta": {
    "title": "Primary_Amenorroea",
    "url": "https://brainandscalpel.vercel.app/primary-amenorroea-409413d4.html",
    "scrapedAt": "2025-11-29T18:26:27.420Z"
  },
  "questions": [
    {
      "id": 12058,
      "choices": [
        {
          "id": 48196,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated with hematometra and hamatocolpos</span></span></span></span></p>"
        },
        {
          "id": 48197,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyclic pelvic pain is experienced</span></span></span></span></p>"
        },
        {
          "id": 48198,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Breast development is absent/ delayed</span></span></span></span></p>"
        },
        {
          "id": 48199,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cruciate incision will relieve symptoms</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 16-year-old girl presents to OPD and the below examination finding is seen. Which of the following is least likely?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/whatsapp-image-2023-04-29-at-154259.jpeg\" style=\"height:321px; width:300px\" /></span></span></p>",
      "unique_key": "Q4471725",
      "question_audio": null,
      "question_video": null,
      "map_id": 12016,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Breast development is absent/ delayed</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The finding here is that of an imperforate hymen</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this there is obstructed outflow to menstrual blood which accumulates in the vagina (hematocolpos) and in the uterus (hematometra) and presents as primary amenorrhoea with presence of secondary sexual characters (as the HPO axis is normal) with a bluish bulge at the introitus. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at each option:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Associated with Hematometra and Hematocolpos</strong>. An imperforate hymen can lead to the hematocolpos and hematometra due to the obstruction of menstrual flow.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cyclic Pelvic Pain is Experienced</strong>: The accumulation of menstrual blood in the vagina and uterus often causes cyclic pelvic pain, which coincides with menstrual cycles , known as cryptomenorrhea.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Breast Development is Absent/Delayed</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Least likely. In cases of imperforate hymen, the hypothalamic-pituitary-ovarian (HPO) axis is intact, and normal secondary sexual characteristics, including breast development, are usually present</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Cruciate Incision will Relieve Symptoms</strong>: A cruciate incision of the hymen is a common surgical intervention to relieve symptoms by allowing the accumulated menstrual blood to drain, thus relieving pain and pressure.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In cases of imperforate hymen, patients typically present with symptoms like primary amenorrhea, cyclic pelvic pain, and a bulging hymen due to the accumulation of menstrual blood in the vagina and uterus (hematocolpos and hematometra). These individuals usually have normal secondary sexual development since the hormonal axis is intact. Surgical intervention, such as a cruciate incision of the hymen, is effective in relieving these symptoms.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Speroff&rsquo;s 9<sup>th</sup> edition chapter 10, amenorrhea</span></span></strong></span></span></p>",
      "correct_choice_id": 48198,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12060,
      "choices": [
        {
          "id": 48204,
          "text": "<p><span style=\"font-size:12.0pt;\">Transverse vaginal septum</span></p>"
        },
        {
          "id": 48205,
          "text": "<p><span style=\"font-size:12.0pt;\">Imperforate hymen</span></p>"
        },
        {
          "id": 48206,
          "text": "<p><span style=\"font-size:12.0pt;\">MRKH</span></p>"
        },
        {
          "id": 48207,
          "text": "<p><span style=\"font-size:12.0pt;\">Nulliparous prolapse</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 17-year-old girl presents to OPD with cyclic pelvic pain local examination reveals the below image.&nbsp; The diagnosis is?</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture2_D8Jfh1v.jpg\" alt=\"\" width=\"300\" height=\"364\"></span></p>",
      "unique_key": "Q4392056",
      "question_audio": null,
      "question_video": null,
      "map_id": 12017,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B. Imperforate hymen</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The finding here is that of an imperforate hymen</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In this there is obstructed outflow to menstrual blood which accumulates in the vagina (hematocolpos) and in the uterus (hematometra) and presents as primary amenorrhoea with presence of secondary sexual characters (as the HPO axis is normal) with a bluish bulge at the introitus.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Let's look at the other options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Transverse Vaginal Septum</strong>: This is a congenital blockage within the vagina. While it can cause similar symptoms like primary amenorrhea and pelvic pain due to menstrual blood accumulation, <strong>it usually does not present with a bulging, blue perineal membrane as seen in the image.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C.</strong>&nbsp; <strong>Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome</strong>: MRKH syndrome involves congenital absence or underdevelopment of the uterus and vagina. Patients usually present with primary amenorrhea but without cyclic pain or a bulging hymen, as they typically lack functional uterine and upper vaginal tissue.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D</strong>.&nbsp;<strong>Nulliparous Prolapse</strong>: Nulliparous prolapse, or pelvic organ prolapse in a woman who has not given birth, would not present with a bulging, blue membrane at the vaginal entrance and is unrelated to primary amenorrhea or cyclic pelvic pain.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An imperforate hymen presents with primary amenorrhea, cyclic pelvic pain, and a bulging, blue hymenal membrane, indicating hematocolpos (accumulation of menstrual blood in the vagina). This condition can be relieved by surgical incision of the hymen to allow for normal menstrual flow.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref: Speroff’s 9<sup>th</sup> edition chapter 10, amenorhea</strong></span></p>",
      "correct_choice_id": 48205,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12061,
      "choices": [
        {
          "id": 48208,
          "text": "<p><span style=\"font-size:12.0pt;\">Transverse vaginal septum</span></p>"
        },
        {
          "id": 48209,
          "text": "<p><span style=\"font-size:12.0pt;\">Imperforate hymen</span></p>"
        },
        {
          "id": 48210,
          "text": "<p><span style=\"font-size:12.0pt;\">Mullerian agenesis</span></p>"
        },
        {
          "id": 48211,
          "text": "<p><span style=\"font-size:12.0pt;\">OHVIRA syndrome</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 16-year-old girl presents to OPD with primary amenorrhea and cyclic pelvic pain. On rectal examination, a bulge is felt anteriorly, 4 cm above the anal verge. The likely diagnosis is:</span></p>",
      "unique_key": "Q3431357",
      "question_audio": null,
      "question_video": null,
      "map_id": 12018,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A. Transverse vaginal septum</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A transverse vaginal septum is the most likely diagnosis as she has primary amenorrhoea with cyclical pelvic pain thereby pointing to a complete obstruction to the outflow of menstrual blood. A rectal exam showing the obstruction high up indicates that the obstruction is higher up in the vagina, thereby pointing to a transverse vaginal septum</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B:&nbsp;</strong>Imperforate hymen will have a bulge at the introitus. And on per rectal examination, swelling will be palpable from anal verge.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C:&nbsp;</strong>MRKH has a vaginal dimple, and no bulge will be felt on per rectal examination</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D:&nbsp;</strong>OHVIRA: obstructed hemi vagina and ipsilateral renal agenesis is a syndrome characterized by uterus didelphys, unilateral vaginal obstruction, and ipsilateral renal agenesis. The patient has normal menses from one hemi uterus and features of cyclic pelvic pain and hematocolpos on side of obstructed hemivagina.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-105747.jpg\" alt=\"\" width=\"500\" height=\"527\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Thus <strong>option A.</strong> transverse vaginal septum is correct&nbsp; based on the description ,since the bulge is not at the introitus but higher up.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A transverse vaginal septum presents with primary amenorrhea and cyclic pelvic pain due to hematocolpos formation above the level of the obstruction. Diagnosis is suggested by a normal vaginal orifice and a palpable mass on rectal examination. Recognition and surgical treatment of this congenital anomaly are essential to relieve symptoms and prevent long-term complications.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref: Speroff’s 9<sup>th</sup> edition chapter 10, amenorrhea</strong></span></p>",
      "correct_choice_id": 48208,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12062,
      "choices": [
        {
          "id": 48212,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">OHVIRA syndrome</span></span></span></span></p>"
        },
        {
          "id": 48213,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MRKH syndrome</span></span></span></span></p>"
        },
        {
          "id": 48214,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ACUM </span></span></span></span></p>"
        },
        {
          "id": 48215,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Robert&rsquo;s uterus</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 17-year-old woman presents to OPD with painful menstruation. On examination, normal secondary sexual characters are present. The vagina is patent but shows a bulge on the right side near the cervix. On per rectal examination, there is a bulge felt about 4 cm from anal verge and is more towards left side. On Ultrasound, there is hematocolpos and the left side kidney is absent. </span></span><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosis is: </span></span></span></span></p>",
      "unique_key": "Q5485439",
      "question_audio": null,
      "question_video": null,
      "map_id": 12019,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. OHVIRA syndrome</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options A. OHVIRA:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">obstructed hemi vagina and ipsilateral renal agenesis is a syndrome characterized by uterus didelphys, unilateral vaginal obstruction, and ipsilateral renal agenesis. The patient has normal menses from one hemi uterus and features of cyclic pelvic pain and hematocolpos on side of obstructed hemivagina. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-105747_O1cNPjD.jpg\" style=\"height:527px; width:500px\" /></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MRKH syndrome can have absent kidney / renal and skeletal abnormalities but usually does not have hematocolpos</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ACUM is an accessory and cavitated uterine horn. Patients present with dysmenorrhea and features similar to endometriosis. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robert uterus is a rare uterine anomaly with asymmetrical uterine septum resulting in obstructed hemi cavity resulting in hematometra on one side. Patient has normal menses with dysmenorrhea. No bulge in vagina will be felt. On per rectal examination, the bulge may not be palpable as mostly hematometra and hematosalpinx is more likely and there is no hematocolpos. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-110058.jpg\" style=\"height:321px; width:400px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: OHVIRA syndrome is characterized by a uterine anomaly such as uterine didelphys with obstructed hemivagina leading to hematocolpos, often accompanied by ipsilateral renal agenesis. This syndrome should be considered in patients presenting with painful menstruation, a unilateral vaginal bulge, and corresponding renal anomalies on imaging. Diagnosis and management of OHVIRA syndrome are crucial for alleviating symptoms and addressing potential reproductive complications.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Speroff&rsquo;s 9<sup>th</sup> edition chapter 10, amenorrhea</span></span></strong></p>",
      "correct_choice_id": 48212,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12063,
      "choices": [
        {
          "id": 48216,
          "text": "<p><span style=\"font-size:12.0pt;\">Complete AIS</span></p>"
        },
        {
          "id": 48217,
          "text": "<p><span style=\"font-size:12.0pt;\">Partial AIS</span></p>"
        },
        {
          "id": 48218,
          "text": "<p><span style=\"font-size:12.0pt;\">MRKH</span></p>"
        },
        {
          "id": 48219,
          "text": "<p><span style=\"font-size:12.0pt;\">Swyer syndrome</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 18 year old girl presents to OPD with primary amenorrhea, normal breast and pubic &amp; axillary hair development. On examination, vagina is absent. Serum estradiol and FSH level are normal. USG shows absent uterus and vagina. The likely diagnosis is:</span></p>",
      "unique_key": "Q8503163",
      "question_audio": null,
      "question_video": null,
      "map_id": 12020,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. C. MRKH</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">This is a case of MRKH (mullerian agenesis) with inguinal hernia</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Normal secondary sexual characteristics, absent vagina and absent uterus, normal hormones point towards MRKH.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">They exhibit normal, symmetrical breast and pubic hair development,</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">have no visible vagina and have no symptoms or signs of cryptomenorrhea because the rudimentary uteri contain no functional endometrium.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Renal and skeletal abnormalities may be associated.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">The ovaries are entirely normal histologically and functionally, although their location in the pelvis may be higher, positioned at or even above the level of the pelvic brim; one or both also may be hypoplastic or associated with an inguinal hernia. </span><span style=\"background-color:transparent;font-size:16px;\">Inguinal hernia is rare in MRKH, but known due to ectopic ovaries</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option&nbsp;A.</strong>&nbsp;<strong>Complete Androgen Insensitivity Syndrome (AIS)</strong>: In complete AIS, individuals have a 46,XY karyotype and testes, but due to a complete inability to respond to androgens, they develop female external genitalia. However, they typically have normal breast development <strong>but no pubic or axillary hair</strong>. The presence of normal pubic and axillary hair development makes complete AIS less likely in this case.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option&nbsp;B.</strong>&nbsp;<strong>Partial AIS</strong>: Partial AIS involves some degree of androgen insensitivity, leading to a spectrum of genital ambiguity. The presence of normal female secondary sexual characteristics and an inguinal hernia may be consistent with partial AIS, but the absent uterus and vagina are not typical for this condition.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option&nbsp;D.</strong>&nbsp;<strong>Swyer Syndrome</strong>: Swyer syndrome, or 46XY pure gonadal dysgenesis, presents with a 46XY karyotype and streak gonads but with female external genitalia. Individuals typically have primary amenorrhea and underdeveloped secondary sexual characteristics due to the lack of functional ovaries. The presence of normal breast development and pubic/axillary hair makes this diagnosis less likely.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">In cases of primary amenorrhea with normal female secondary sexual characteristics and the absence of the uterus and vagina, Mayer-Rokitansky-Küster-Hauser syndrome is a likely diagnosis. MRKH syndrome is characterized by the congenital absence of the uterus and upper vagina while maintaining normal ovarian function and external secondary sexual characteristics.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ref: Speroff’s 9<sup>th</sup> edition chapter 10, amenorrhea</strong></span></p>",
      "correct_choice_id": 48218,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12064,
      "choices": [
        {
          "id": 48220,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaginoplasty</span></span></span></span></p>"
        },
        {
          "id": 48221,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaginoplasty, and IVF with self-oocyte and surrogacy</span></span></span></span></p>"
        },
        {
          "id": 48222,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaginoplasty and IVF with donor oocyte and surrogacy</span></span></span></span></p>"
        },
        {
          "id": 48223,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vaginoplasty and donor embryo and surrogacy</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20-year-old girl presents to OPD with primary amenorrhea and evaluation reveals MRKH. Treatment for patients with MRKH includes: </span></span></span></span></p>",
      "unique_key": "Q4673613",
      "question_audio": null,
      "question_video": null,
      "map_id": 12021,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Vaginoplasty, and IVF with self-oocyte and surrogacy</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The 2 goals of treatment in MRKH syndrome are: Sexual function and Fertility</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sexual function</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Creation of a functional vagina. This can be achieved</span></span></span></span>\r\n\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t<li style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Surgically &ndash; McIndoe&rsquo;s vaginoplasty</span></span></span></span></li>\r\n\t\t\t<li style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-surgical: Using vaginal dilators (Fran dilators)</span></span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fertility</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Advances in assisted reproductive technologies with the use of gestational surrogacy option have allowed attainment of genetic offspring by in vitro fertilization (IVF) using oocytes retrieved from their own normal ovaries and the sperm of their chosen partner, with subsequent transfer of embryos to a gestational surrogate.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the past decade, uterine transplantation has moved leaps and bounds, may emerge as a treatment option.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Let&#39;s look at each option:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>A.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Vaginoplasty</strong>: This treatment alone does not address the issue of fertility, as these patients typically lack a functional uterus.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>B.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Vaginoplasty, and IVF with Self-Oocyte and Surrogacy</strong>: Correct. This option includes vaginoplasty to create a vagina and the use of in vitro fertilization (IVF) with the patient&#39;s own oocytes. Because women with MRKH typically have normal ovaries, they can produce eggs for IVF. The fertilized embryos can then be carried by a surrogate mother, as patients with MRKH lack a uterus.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Vaginoplasty and IVF with Donor Oocyte and Surrogacy</strong>: This option is not typically necessary for MRKH patients, as they usually have functional ovaries and can use their own oocytes for IVF. The use of donor oocytes would be considered if there were an issue with the patient&#39;s egg quality or quantity.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Vaginoplasty and Donor Embryo and Surrogacy</strong>: Similar to option C, this approach would only be necessary if there were issues with the patient&#39;s oocytes. As women with MRKH generally have normal ovarian function, they can typically use their own oocytes for IVF.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: For patients with MRKH syndrome, treatment can include vaginoplasty to construct a functional vagina and IVF using self-oocytes, with the embryo being carried by a surrogate mother. This approach addresses both the anatomical challenge of the absent vagina and the issue of fertility due to the absence of a functional uterus.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Speroff&rsquo;s 9<sup>th</sup> edition chapter 10, amenorrhea</span></span></strong></p>",
      "correct_choice_id": 48221,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12065,
      "choices": [
        {
          "id": 48224,
          "text": "<p><span style=\"font-size:12.0pt;\">Karyotype will most likely be 46XX</span></p>"
        },
        {
          "id": 48225,
          "text": "<p><span style=\"font-size:12.0pt;\">Associated with renal and skeletal anomalies</span></p>"
        },
        {
          "id": 48226,
          "text": "<p><span style=\"font-size:12.0pt;\">Gonadectomy and vaginoplasty are recommended treatment</span></p>"
        },
        {
          "id": 48227,
          "text": "<p><span style=\"font-size:12.0pt;\">Immediate Gonadectomy is done immediately</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 20-year-old girl presents to OPD with primary amenorrhea. Height is 160 cm, has normal breast development and absent pubic hair. The uterus and vagina are absent. Which of the following is true?</span></p>",
      "unique_key": "Q4930693",
      "question_audio": null,
      "question_video": null,
      "map_id": 12022,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. C. Gonadectomy and vaginoplasty are recommended treatment</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The presented case is of Androgen Insensitivity Syndrome</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Patients with complete AIS most commonly present after the age of puberty in late adolescence or as young adults with primary amenorrhea. They exhibit asymmetrical secondary sexual development (breast development with absent or scant pubic hair), have a short vagina with no visible cervix, and have no other symptoms or complaints.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Serum testosterone concentration easily distinguishes patients with AIS from those with Müllerian agenesis because levels are normal or modestly elevated well above the normal range for females and often above the range observed in normal males. Serum LH levels also are elevated, reflecting androgen insensitivity at the hypothalamus-pituitary level. A karyotype (46XY) firmly establishes the diagnosis.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In patients with AIS, the options for creation of a neovagina are the same as for those with Müllerian agenesis</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Complete AIS is the only exception to the rule that gonads with a Y chromosome should be removed as soon as the diagnosis is made.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Let's evaluate each option:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Karyotype will most likely be 46XX</strong>: False. The presence of normal breast development and absent pubic hair suggests Androgen Insensitivity Syndrome (AIS), where the karyotype is typically 46XY. Mullerian agenesis will have pubic hair development</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Associated with renal and skeletal anomalies</strong>: False. While renal and skeletal anomalies are commonly associated with MRKH syndrome, they are not a typical feature of Androgen Insensitivity Syndrome (AIS). Mullerian agenesis will have pubic hair development</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Gonadectomy and Vaginoplasty are recommended treatment</strong>: Correct for AIS. Patients with complete AIS have testes that produce normal to high levels of testosterone, which gets converted to estrogen, leading to breast development. However, the body is insensitive to testosterone, resulting in scant or absent pubic hair. Gonadectomy is recommended to prevent the risk of gonadal tumors. Vaginoplasty may be performed for the creation of a functional vagina.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Immediate Gonadectomy is done immediately</strong>: Immediate gonadectomy is not typically recommended in complete AIS. It is usually delayed until after puberty to allow for natural estrogen production from the testes, which contributes to female secondary sexual characteristics. Incomplete AIS may require earlier gonadectomy due to a higher risk of gonadal tumors.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In Androgen Insensitivity Syndrome (AIS), which is characterized by a 46XY karyotype, patients typically present with primary amenorrhea, normal breast development, and scant pubic hair due to insensitivity to androgens. Gonadectomy is recommended to prevent gonadal tumor risk, often after puberty to benefit from endogenous estrogen production for sexual development. Vaginoplasty is an option for those who wish to have a functional vagina.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref: Speroff’s 9<sup>th</sup> edition chapter 10, amenorrhea</strong></span></p>",
      "correct_choice_id": 48226,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12067,
      "choices": [
        {
          "id": 48232,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal anomalies</span></span></span></span></p>"
        },
        {
          "id": 48233,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Skeletal anomalies</span></span></span></span></p>"
        },
        {
          "id": 48234,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inguinal hernia </span></span></span></span></p>"
        },
        {
          "id": 48235,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clitoromegaly</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 21-year-old girl presents to OPD with primary amenorrhea, she has normal breast development and scant pubic hair. Labia minora are small and vagina is absent. Which of the following is most likely to be associated with this: </span></span></p>",
      "unique_key": "Q5561905",
      "question_audio": null,
      "question_video": null,
      "map_id": 12024,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Inguinal hernia </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given clinical picture is of complete AIS. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The gonads are testes, and their location may be intra-abdominal, but often are partially descended into the inguinal canal, more than half of patients with complete AIS have an inguinal hernia, and the testes are frequently palpable in the inguinal canals, most commonly at the level of the external inguinal ring.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at each option:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>A.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Renal Anomalies</strong>: They are more commonly associated with conditions like Mayer-Rokitansky-K&uuml;ster-Hauser (MRKH) syndrome, not typically with Complete Androgen Insensitivity Syndrome (AIS).</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>B.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Skeletal Anomalies</strong>: Also seen more frequently in MRKH syndrome not in AIS. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Inguinal Hernia</strong>: Correct. In Complete AIS, the individual has a 46XY karyotype with testes that may be located in the inguinal canal, leading to a higher likelihood of inguinal hernias. More than half of patients with Complete AIS have an inguinal hernia, and the testes are often palpable in the inguinal canals.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Clitoromegaly</strong>: Clitoromegaly is more commonly associated with conditions that involve exposure to higher levels of androgens, such as Congenital Adrenal Hyperplasia (CAH). It is not typically a feature of Complete AIS, where there is insensitivity to androgens.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In Complete Androgen Insensitivity Syndrome (AIS), patients with a 46,XY karyotype present with female external genitalia, normal breast development, and absent or scant pubic hair due to insensitivity to androgens. A common associated condition is the presence of inguinal hernias, as the testes may be located in the inguinal canal. Understanding the clinical presentation and associated features of Complete AIS is essential for accurate diagnosis and appropriate management.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Speroff&rsquo;s 9<sup>th</sup> edition chapter 10, amenorrhea</span></span></strong></span></span></p>",
      "correct_choice_id": 48234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12071,
      "choices": [
        {
          "id": 48248,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">46 XX</span></span></span></span></p>"
        },
        {
          "id": 48249,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">46XY</span></span></span></span></p>"
        },
        {
          "id": 48250,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">45 X0</span></span></span></span></p>"
        },
        {
          "id": 48251,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">47 XXY</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 14-year-old girl presents to OPD with primary amenorrhea. Her height is 135 cm. She has a webbed neck and increased carrying angle. Breast development is tanner 1 with widely spaced nipple, external genitalia are infantile. The Karyotype is most likely to reveal: </span></span></p>",
      "unique_key": "Q7273216",
      "question_audio": null,
      "question_video": null,
      "map_id": 12027,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. 45 X0</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a case of Turner syndrome. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Short stature, widely spaced nipple, short fourth metacarpals, increased carrying angle are typical features of Turner syndrome. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Karyotype is 45X0. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mosaics of 45X0/46XX or 45 X0/46XY may exist. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at the other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>A.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>46 XX</strong>: Normal female karyotype. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>B.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>46 XY</strong>: Normal male karyotype. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>47 XXY</strong>: This karyotype is associated with Klinefelter syndrome, which is characterized by a male phenotype with some level of hypogonadism and gynecomastia, not matching the clinical presentation described in the girl.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In a patient presenting with primary amenorrhea, short stature, webbed neck, widely spaced nipples, and infantile external genitalia, the karyotype most likely to be found is 45 X0, indicative of Turner syndrome. Turner syndrome is characterized by the absence of all or part of a second sex chromosome, leading to various developmental and physical abnormalities. Identification of this condition is crucial for appropriate management and support.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Speroff&rsquo;s 9<sup>th</sup> edition chapter 10, amenorrhea</span></span></strong></p>",
      "correct_choice_id": 48250,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12073,
      "choices": [
        {
          "id": 48256,
          "text": "<p><span style=\"font-size:12.0pt;\">Estrogen therapy</span></p>"
        },
        {
          "id": 48257,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclic Estrogen and progesterone therapy</span></p>"
        },
        {
          "id": 48258,
          "text": "<p><span style=\"font-size:12.0pt;\">Growth hormone and Estrogen therapy</span></p>"
        },
        {
          "id": 48259,
          "text": "<p><span style=\"font-size:12.0pt;\">Growth hormone and cyclic Estrogen-progesterone therapy</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 13-year-old girl with primary amenorrhea, short stature, and hypergonadotropic hypogonadism. Karyotype reveals 45X0. What is the next line of management?</span></p>",
      "unique_key": "Q4934599",
      "question_audio": null,
      "question_video": null,
      "map_id": 12029,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. C. Growth hormone and Estrogen therapy</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">With early diagnosis and treatment with growth hormone (GH), a final height greater than 150 cm can be achieved in most patients with Turner syndrome.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">The most important determinants of final height are the dose of GH and the duration of treatment before estrogen therapy begins.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Treatment with GH generally should begin as soon as growth curve falls below the fifth percentile of normal female growth, and the regimen must be individualized, according to response.&nbsp;</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Treatment with estrogen must be timed carefully, with the goals of minimizing its adverse effects on growth and adult height and inducing puberty at an approximately normal age.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Ideally, estrogen therapy should begin no later than age 15 and not before age 12 when growth is a priority, unless height already has been maximized.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Estrogen therapy should begin at a low dose (e.g., 0.25-0.5 mg micronized oestradiol or its equivalent), increasing gradually at intervals of 3-6 months according to response (Tanner stage, bone age), with the goal of completing sexual maturation over a period of 2-3 years.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>When vaginal bleeding first occurs, or after 12-24 months of estrogen therapy, a progestin (e.g., MPA) should be added to the treatment regimen to prevent dysfunctional bleeding, to achieve differentiation of breast tissue, and to protect the endometrium from long-term adverse effects of unopposed estrogen</strong></span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Let's explore each option:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option&nbsp;A.</strong>&nbsp;<strong>Estrogen Therapy</strong>: Estrogen therapy is used in Turner syndrome to induce secondary sexual characteristics and maintain female sex hormone levels. However, initiating estrogen therapy alone may not address short stature, a common issue in Turner syndrome.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option&nbsp;B</strong>.&nbsp;<strong>Cyclic Estrogen and Progesterone Therapy</strong>: This therapy is appropriate for inducing and maintaining secondary sexual characteristics and menstrual cycles. However, it does not address the short stature associated with Turner syndrome. </span><span style=\"background-color:transparent;font-size:16px;\">Full HRT is used later after height is optimized.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option&nbsp;C.</strong>&nbsp;<strong>Growth Hormone and Estrogen Therapy</strong>: Correct. Growth hormone therapy is recommended to address short stature in Turner syndrome. It should ideally begin as early as possible, and estrogen therapy should be initiated carefully to induce puberty without adversely affecting growth.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option&nbsp;D</strong>.&nbsp;<strong>Growth Hormone and Cyclic Estrogen-Progesterone Therapy</strong>: While this combination addresses both growth and the development of secondary sexual characteristics, the initiation of cyclic estrogen-progesterone therapy may be deferred until after maximizing height with growth hormone therapy.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">For a patient with Turner syndrome presenting with short stature and primary amenorrhea, the recommended management includes growth hormone therapy to address short stature and estrogen therapy to induce secondary sexual characteristics. The timing and dosage of estrogen therapy are critical to balance the induction of puberty with the potential impact on growth. Growth hormone therapy should ideally begin when the growth curve falls below the fifth percentile, and estrogen therapy should start between the ages of 12 and 15, gradually increasing over time</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ref: Speroff’s 9<sup>th</sup> edition chapter 10, amenorrhea</strong></span></p>",
      "correct_choice_id": 48258,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12075,
      "choices": [
        {
          "id": 48264,
          "text": "<p><span style=\"font-size:12.0pt;\">Karyotype</span></p>"
        },
        {
          "id": 48265,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclic Estrogen and progesterone</span></p>"
        },
        {
          "id": 48266,
          "text": "<p><span style=\"font-size:12.0pt;\">Gonadectomy</span></p>"
        },
        {
          "id": 48267,
          "text": "<p><span style=\"font-size:12.0pt;\">Vaginoplasty</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 17-year-old girl presents to OPD for not having attained menses till now. On examination, height is 170 cm, breasts are not well developed, pubic hair are absent, external genitalia are normal and vagina and uterus are present. Serum FSH is high. What is the next step?</span></p>",
      "unique_key": "Q6172086",
      "question_audio": null,
      "question_video": null,
      "map_id": 12030,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A. Karyotype</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The clinical picture is of Swyer syndrome. (46XY dysgenesis)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">But to differentiate it from 46 XX gonadal dysgenesis or premature ovarian failure, a karyotype must be done before proceeding with gonadectomy.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Let us look at each option:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Karyotype</strong>: Correct. Given the clinical presentation, a karyotype test is essential to determine the chromosomal pattern, which will help in diagnosing conditions like Swyer syndrome (46,XY gonadal dysgenesis) or other forms of gonadal dysgenesis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B</strong>.&nbsp;<strong>Cyclic Estrogen and Progesterone</strong>: Hormone replacement therapy with estrogen and progesterone may be necessary to induce secondary sexual characteristics and regular menstrual cycles, but it should only be initiated after a definitive diagnosis is made via karyotyping.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Gonadectomy</strong>: Gonadectomy may be indicated in cases of Swyer syndrome due to the increased risk of gonadoblastoma in streak gonads. However, this should only be considered after a definitive diagnosis is confirmed through karyotyping.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D</strong>.&nbsp;<strong>Vaginoplasty</strong>: Vaginoplasty is a surgical procedure to create or reconstruct a vagina. This is not indicated in this case, as the patient has a normal vagina and external genitalia.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>: In a patient with primary amenorrhea, underdeveloped breasts, and elevated serum FSH, karyotyping is the next essential step to differentiate between conditions like Swyer syndrome (46,XY gonadal dysgenesis) and other forms of gonadal dysgenesis. This will guide further management, including the possibility of hormone replacement therapy or gonadectomy, depending on the diagnosis</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref:&nbsp;Speroff’s 9<sup>th</sup> edition chapter 10, amenorrhea</strong></span></p>",
      "correct_choice_id": 48264,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12076,
      "choices": [
        {
          "id": 48268,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Androgen insensitivity syndrome</span></span></span></span></p>"
        },
        {
          "id": 48269,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Constitutional delay</span></span></span></span></p>"
        },
        {
          "id": 48270,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Functional hypothalamic amenorrhoea</span></span></span></span></p>"
        },
        {
          "id": 48271,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mullerian agenesis</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 16y girl is brought to the OPD as she has not started her period. The patients 14y sister underwent menarche 2 years earlier and her mother began menstruating at age 13. She has no weight gain, headaches, nipple discharge or abdominal pain. She is not sexually active and is not using any method of contraception. She is physically active and is on her school&rsquo;s basketball team. Her breast exam and pubic hair are Tanner stage IV. The abdomen is soft. The external genitalia appear normal. The vagina ends in a blind pouch. An ultrasound reveals ovaries, but no cervix or uterus is seen. Which is the most likely diagnosis?</span></span></span></span></p>",
      "unique_key": "Q1834105",
      "question_audio": null,
      "question_video": null,
      "map_id": 12031,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Mullerian agenesis</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mullerian agenesis is also known as MRKH syndrome</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is no Mullerian structure (Absent uterus, cervix, fallopian tubes, upper 2/3<sup>rd</sup> of vagina) but ovaries are present</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">So patient presents as primary amenorrhoea with normal secondary sexual characters</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All hormonal levels are normal</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Skeletal and renal anomalies may be associated</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Karyotype: 46XX</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fertility: Surrogacy, uterine transplant (upcoming)</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sexual: Vaginoplasty</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at the other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>A.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Androgen Insensitivity Syndrome</strong>: 46XY karyotype develop female external genitalia due to androgen receptor insensitivity. However, breast development is usually normal or above average due to peripheral conversion of androgens to estrogens. The presence of Tanner stage IV breast development and pubic hair is less typical for AIS, which usually presents with scant or absent pubic hair.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Constitutional Delay</strong>: A variation of normal development where puberty and associated milestones, such as menarche, occur later than average. However, the presence of Tanner stage IV breast development and pubic hair indicates that puberty has progressed, making this less likely.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Functional Hypothalamic Amenorrhea: This</strong> is associated with stress, significant weight loss, or excessive exercise and results in suppressed gonadotropin-releasing hormone (GnRH) secretion. This diagnosis is less likely given the patient&#39;s normal development of secondary sexual characteristics and absence of weight loss or other stress factors.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In a patient with primary amenorrhea, normal secondary sexual development, and a blind-ending vaginal pouch with absent uterus and cervix on ultrasound, M&uuml;llerian agenesis is the most likely diagnosis. This condition is characterized by the congenital absence of the uterus and part of the vagina while maintaining normal ovarian function and external genitalia. Diagnosis is crucial for appropriate management and support.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: </span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Speroff&rsquo;s 9<sup>th</sup> edition chapter 10, amenorrhea</span></span></strong></span></span></p>",
      "correct_choice_id": 48271,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12078,
      "choices": [
        {
          "id": 48276,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">47XXY</span></span></span></span></p>"
        },
        {
          "id": 48277,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">46 XY</span></span></span></span></p>"
        },
        {
          "id": 48278,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">45 XO</span></span></span></span></p>"
        },
        {
          "id": 48279,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">46 XX</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 15y old is brought to the OPD by her mother due to concerns that her mother has not had her menses. She was born at 36 weeks and has had no developmental delay. She is doing well in school and plays on the tennis team. She is healthy and takes no medications. She is not sexually active. She does not consume alcohol or smoke. Her maternal aunt has primary infertility and maternal grandmother had ovarian cancer. Her height is 5&rsquo;7 and weight is 63kg. There is no acne or hirsutism. Breast dev is Tanner stage 5. There is scanty axillary and pubic hair. On pelvic exam, external genitalia appear normal and speculum shows a blind vaginal pouch. On ultrasound, uterus and ovaries are absent. What is the likely karyotype?</span></span></span></span></p>",
      "unique_key": "Q2542491",
      "question_audio": null,
      "question_video": null,
      "map_id": 12032,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B.&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">46 XY</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patient has androgen insensitivity syndrome</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a X linked recessive condition where the genotype is 46XY. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenotypically they are female.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Testes produce both AMH and testosterone.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Testosterone has no activity on peripheral tissues. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AMH causes regression of mullerian structures. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These patients present as:</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary amenorrhoea</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Breast development</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal female external genitalia</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s explore the other options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>A.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>47XXY</strong>: Associated with Klinefelter syndrome, typically presents in males with small testes, reduced secondary sexual characteristics, infertility, and sometimes gynecomastia. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>45XO</strong>: Associated with Turner syndrome, typically presenting with short stature, primary amenorrhea, and sometimes other physical anomalies. Turner syndrome patients usually have underdeveloped secondary sexual characteristics.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>46XX</strong>: This is a normal female karyotype. The clinical features described, particularly the absence of the uterus and ovaries and the presence of normal breast development with scanty axillary and pubic hair, are not typical for a 46XX karyotype.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In a patient presenting with primary amenorrhea, normal breast development, scanty body hair, normal external genitalia, and absence of the uterus and ovaries, the likely diagnosis is Androgen Insensitivity Syndrome (AIS), associated with a 46XY karyotype. Patients with AIS develop female external genitalia due to their body&#39;s insensitivity to androgens. Understanding the karyotype and associated clinical features is essential for diagnosis and management</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 376, DC Duttas&rsquo;s Textbook of Gynecology 8<sup>th</sup> edition</span></span></strong></p>",
      "correct_choice_id": 48277,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12079,
      "choices": [
        {
          "id": 48280,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Karyotype</span></span></span></span></p>"
        },
        {
          "id": 48281,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MRI brain</span></span></span></span></p>"
        },
        {
          "id": 48282,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pelvic USG</span></span></span></span></p>"
        },
        {
          "id": 48283,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reassurance </span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 14y girl is brought to the OPD as she has not yet attained her period. She has no headache, nipple discharge or abdominal pain. She takes a topical retinoid and a topical antibiotic for acne. Her last visit was 3 months ago for evaluation of gastroenteritis. Her mother is diabetic. She has 2 older sisters both of whom underwent menarche at 13 years. Since the last appointment, her height has increased by 5 cm. Examination shows acne on the face. Breast development and pubic hair are tanner stage 4. What is the next best step?</span></span></span></span></p>",
      "unique_key": "Q5348204",
      "question_audio": null,
      "question_video": null,
      "map_id": 12033,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Reassurance</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient is 14y with normal secondary sexual characters</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">She also has a growth spurt </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is most likely constitutional </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">No further investigations are warranted</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Re-evaluate if menarche does not occur by age 15y</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at each option:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>A.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Karyotype</strong>: Karyotyping is used to identify chromosomal abnormalities, typically indicated in cases of abnormal sexual development or primary amenorrhea. Normal Tanner stage 4 development makes a chromosomal abnormality less likely.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>MRI Brain</strong>: Particularly the pituitary region, is indicated in cases where there are symptoms suggestive of a central cause of amenorrhea, such as headaches or visual changes. This patient does not have such symptoms.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pelvic Ultrasound (USG)</strong>: It is useful for evaluating the internal reproductive organs. However, given this patient&#39;s normal secondary sexual development and lack of other concerning symptoms, it may not be immediately necessary.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Reassurance</strong>: Correct. The patient shows normal secondary sexual characteristics and a recent growth spurt, which suggests that she is progressing normally through puberty. Primary amenorrhea at this stage, especially given her normal development, is likely constitutional and not immediately concerning. Reassurance and observation are appropriate, with re-evaluation recommended if menarche does not occur by age 15.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In a 14-year-old girl with primary amenorrhea but normal secondary sexual development and recent growth, reassurance and observation are appropriate initial steps. Most girls experience menarche by age 15, and the absence of menarche by this age would warrant further evaluation. It&#39;s important to consider the normal variability in the timing of pubertal milestones when assessing adolescents.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 376, DC Duttas&rsquo;s Textbook of Gynecology 8<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48283,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12081,
      "choices": [
        {
          "id": 48288,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">12-year-old with Tanner stage I breast development</span></span></span></span></p>"
        },
        {
          "id": 48289,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">16-year-old with Tanner stage II breast development </span></span></span></span></p>"
        },
        {
          "id": 48290,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">14-year-old with Tanner stage III breast development </span></span></span></span></p>"
        },
        {
          "id": 48291,
          "text": "<p><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">18-year-old with Tanner stage V breast development and cessation of menses for the last two cycles</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following clinical scenarios meets the definition of amenorrhea?</span></span></span></span></p>",
      "unique_key": "Q7976684",
      "question_audio": null,
      "question_video": null,
      "map_id": 12035,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. 16-year-old with Tanner stage II breast development </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Definition of primary amenorrhoea is:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Failure to attain menarche by the age of 13y in the absence of secondary sexual characters OR</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Failure to attain menarche by the age of 15y in the presence of secondary sexual characters</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Definition of secondary amenorrhoea</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cessation of periods for 6 months or 3 or more periods</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The only option which fulfils these criteria is option &ldquo;B&rdquo; i.e., 16y old with Tanner stage 2 breast development</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look&nbsp; at each option :</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. 12-year-old with Tanner Stage I Breast Development</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: within the normal range for a girl to not have achieved menarche, especially with Tanner Stage I breast development, indicating early puberty.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>16-year-old with Tanner Stage II Breast Development</strong>: Correct. According to the definition, primary amenorrhea is the failure to attain menarche by age 15 with the presence of secondary sexual characteristics. A 16-year-old with Tanner Stage II breast development meets this criterion for primary amenorrhea.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. 14-year-old with Tanner Stage III Breast Development</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: development is still within the normal range for not having achieved menarche.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>18-year-old with Tanner Stage V Breast Development and Cessation of Menses for the Last Two Cycles</strong>: This scenario describes secondary amenorrhea, which is defined as the cessation of menses for six months or the absence of three or more consecutive menstrual cycles. Since the cessation in this case is only for two cycles, it does not meet the definition of secondary amenorrhea.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Primary amenorrhea is defined as the absence of menarche by age 15 in the presence of secondary sexual characteristics or by age 13 in the absence of secondary sexual characteristics. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Speroff&rsquo;s 9<sup>th</sup> edition chapter 10, amenorrhea</span></span></strong></span></span></p>",
      "correct_choice_id": 48289,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12082,
      "choices": [
        {
          "id": 48292,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovary</span></span></span></span></p>"
        },
        {
          "id": 48293,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Testis</span></span></span></span></p>"
        },
        {
          "id": 48294,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paroophoron</span></span></span></span></p>"
        },
        {
          "id": 48295,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epoophoron</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An 18-year-old nulligravid female presents with primary amenorrhea. During examination, Tanner stage 4 breast development and sparse pubic and axillary hair are noted. Also, a blind-ending vagina is identified. The patient undergoes a laparoscopy. The white oval structure seen represents what? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture6_FJDDIEk.jpg\" style=\"height:240px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q7342940",
      "question_audio": null,
      "question_video": null,
      "map_id": 12036,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Testis</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The scenario given is most likely androgen insensitivity syndrome</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The structure shown is the male gonad (testis)</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These need to be removed (gonadectomy) as the incidence of malignancy is very high.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s consider each option:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>A.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ovary</strong>: In typical female anatomy, ovaries are present. However, the clinical features described here, including the blind-ending vagina and sparse body hair despite breast development, are not consistent with typical female internal genital anatomy.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Testis</strong>: Correct. This scenario is indicative of Androgen Insensitivity Syndrome (AIS), a condition where an individual with a 46XY karyotype develops female external genitalia. In AIS, the gonads are testes, not ovaries. The risk of gonadal malignancy warrants their removal.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Paroophoron</strong>: The paroophoron (of Johnson) is also a remnant of the Mesonephric duct. It is situated between the epoophoron and the uterus.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Epoophoron</strong>: The&nbsp;<strong>epoophoron</strong>&nbsp;(also called&nbsp;<strong>organ of Rosenm&uuml;ller</strong>&nbsp;or the&nbsp;<strong>parovarium</strong>) is a remnant of the&nbsp;Mesonephric duct&nbsp;that can be found next to the&nbsp;ovary&nbsp;and&nbsp;fallopian tube.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In a patient with primary amenorrhea, female external genitalia, but with internal male gonads (testes), the diagnosis of Androgen Insensitivity Syndrome should be considered. These patients have a 46XY karyotype and testes that are typically undescended. Due to the risk of gonadal malignancy, gonadectomy is recommended</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 376, DC Duttas&rsquo;s Textbook of Gynecology 8<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48293,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12083,
      "choices": [
        {
          "id": 48296,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Male level</span></span></span></span></p>"
        },
        {
          "id": 48297,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Female level</span></span></span></span></p>"
        },
        {
          "id": 48298,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Not measurable</span></span></span></span></p>"
        },
        {
          "id": 48299,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Significantly elevated (&gt;1000 ng/dL)</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the expected testosterone level in a patient with mullerian agenesis?</span></span></p>",
      "unique_key": "Q9838249",
      "question_audio": null,
      "question_video": null,
      "map_id": 12037,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Female level</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mullerian agenesis is also known as MRKH syndrome</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is no Mullerian structure (Absent uterus, cervix, fallopian tubes, upper 2/3<sup>rd</sup> of vagina) but ovaries are present</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">So, patient presents as primary amenorrhoea with normal secondary sexual characters</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All hormonal levels are normal (so testosterone will be as of female level)</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Skeletal and renal anomalies may be associated</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Karyotype: 46XX</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment:</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fertility: Surrogacy, uterine transplant (upcoming)</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sexual: Vaginoplasty</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at each option:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Male Level</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This would be expected in conditions like Androgen Insensitivity Syndrome, where individuals have a 46XY karyotype and testes that produce male levels of testosterone.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Female Level</strong>: Correct. In M&uuml;llerian agenesis (Mayer-Rokitansky-K&uuml;ster-Hauser syndrome), the individuals usually have a 46XX karyotype and ovaries that produce female levels of hormones, including testosterone. Their testosterone levels would be within the normal female range.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Not Measurable</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Individuals with M&uuml;llerian agenesis typically have ovaries that produce hormones, including measurable levels of testosterone within the female range.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Significantly Elevated (&gt;1000 ng/dL)</strong>: Significantly elevated testosterone levels are likely to be seen in conditions involving adrenal or ovarian tumors or other endocrine disorders.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In patients with M&uuml;llerian agenesis, a condition characterized by the congenital absence of the uterus and part of the vagina, hormone levels, including testosterone, are typically within the normal female range. This condition usually occurs in individuals with a 46,XX karyotype and normally functioning ovaries. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;&nbsp;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Speroff&rsquo;s 9<sup>th</sup> edition chapter 10, amenorrhea</span></span></strong></p>",
      "correct_choice_id": 48297,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12085,
      "choices": [
        {
          "id": 48304,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Streak gonads and male internal genitalia</span></span></span></span></p>"
        },
        {
          "id": 48305,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Streak gonads and female internal genitalia</span></span></span></span></p>"
        },
        {
          "id": 48306,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Empty pelvis (no gonads or internal genitalia)</span></span></span></span></p>"
        },
        {
          "id": 48307,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilateral abdominal testes and male internal genitalia</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old nulligravida presents with primary amenorrhea. She is diagnosed with 46XY gonadal dysgenesis. During pelvic laparoscopy, what is the expected finding?</span></span></p>",
      "unique_key": "Q8387585",
      "question_audio": null,
      "question_video": null,
      "map_id": 12039,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp; B. Streak gonads and female internal genitalia</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The scenario described is 46 XY gonadal dysgenesis (or Swyer syndrome)</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In Swyer syndrome, there will be normal female internal and external genitalia with the presence of male gonads which are non-functional</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The karyotype is 46XY</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us evaluate the expected findings during pelvic laparoscopy:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Streak Gonads and Male Internal Genitalia</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This option would be more typical of complete androgen insensitivity syndrome (CAIS), where individuals with a 46XY karyotype develop female external genitalia but lack female internal genitalia due to the presence of testes that produce male levels of androgens.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Streak Gonads and Female Internal Genitalia</strong>: Correct. In 46XY gonadal dysgenesis, the individual typically has streak gonads (underdeveloped gonadal tissue) instead of fully developed testes or ovaries. Despite the 46XY karyotype, these individuals can have some form of female internal genitalia (like a uterus, although it may be underdeveloped). because the streak gonads do not produce the male hormones necessary to suppress female internal genitalia development. They are phenotypically female</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Empty Pelvis (No Gonads or Internal Genitalia)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is less likely. While gonadal dysgenesis involves underdeveloped gonads (streak gonads), the presence of some internal genitalia is expected, especially in a case with a female phenotype.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Bilateral Abdominal Testes and Male Internal Genitalia</strong>: This scenario is more consistent with a condition like undescended testes in an individual with a male phenotype. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In patients with 46XY gonadal dysgenesis, pelvic laparoscopy typically reveals streak gonads and the presence of female internal genitalia. This condition involves underdeveloped gonadal tissue and the development of female internal genitalia due to the lack of male hormone production. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Speroff&rsquo;s 9<sup>th</sup> edition chapter 10, amenorrhea</span></span></strong></span></span></p>",
      "correct_choice_id": 48305,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12086,
      "choices": [
        {
          "id": 48308,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gonadectomy due to increased risk of malignant transformation in retained gonads</span></span></span></span></p>"
        },
        {
          "id": 48309,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oophoropexy due to increased rate of torsion</span></span></span></span></p>"
        },
        {
          "id": 48310,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometriosis ablation due to increased rate of endometriosis</span></span></span></span></p>"
        },
        {
          "id": 48311,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To see if fertility is possible</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20-year-old female is diagnosed with gonadal dysgenesis, and her karyotype reveals 45, X/46, XY mosaicism. Laparoscopy is performed for which of the following reasons?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture7_D11zrBu.jpg\" style=\"height:353px; width:250px\" /></span></span></p>",
      "unique_key": "Q4279196",
      "question_audio": null,
      "question_video": null,
      "map_id": 12040,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Gonadectomy due to increased risk of malignant transformation in retained gonads</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Whenever there is a 46XY karyotype in primary amenorrhoea, there is a strong likelihood of malignant transformation in the gonads</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hence gonadectomy should be done as soon as possible (In complete AIS, gonadectomy can be delayed till after puberty is complete)</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at each option:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>A.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gonadectomy due to Increased Risk of Malignant Transformation in Retained Gonads</strong>: Correct. Individuals with 45X/46XY mosaicism have an increased risk of gonadal malignancy, especially in the presence of Y chromosome material. Gonadectomy is recommended to reduce this risk, as the dysgenetic gonads in such cases are prone to developing gonadoblastoma and other germ cell tumors.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Oophoropexy due to Increased Rate of Torsion</strong>: Oophoropexy is a surgical procedure to fix the ovaries in place, typically performed to prevent torsion. However, this is not the primary concern in patients with 45, X/46, XY mosaicism, where the risk of malignancy is the more pressing issue.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Endometriosis Ablation due to Increased Rate of Endometriosis</strong>: There is no direct correlation between gonadal dysgenesis with 45, X/46, XY mosaicism and an increased rate of endometriosis. Endometriosis ablation would not be the primary indication for laparoscopy in this scenario.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>To See if Fertility is Possible</strong>: While assessing fertility potential is important, the immediate concern in a patient with 45, X/46, XY mosaicism is the risk of malignant transformation in the gonads. The primary reason for laparoscopy in this case is to perform a gonadectomy, if indicated.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In patients with gonadal dysgenesis and a 45, X/46, XY karyotype, laparoscopy and gonadectomy are recommended due to the increased risk of malignant transformation in retained gonads. This pre-emptive surgical approach is crucial to reduce the risk of gonadal malignancies in these patients</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Speroff&rsquo;s 9<sup>th</sup> edition chapter 10, amenorrhea</span></span></strong></p>",
      "correct_choice_id": 48308,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12089,
      "choices": [
        {
          "id": 48320,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gonadotropin-releasing hormone (GnRH) neurons fail to develop.</span></span></span></span></p>"
        },
        {
          "id": 48321,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a condition that leads to hypergonadotropic hypogonadism.</span></span></span></span></p>"
        },
        {
          "id": 48322,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intact sense of smell differentiates it from other similar conditions.</span></span></span></span></p>"
        },
        {
          "id": 48323,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Can be inherited as an autosomal dominant or autosomal recessive disorder</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is true of Kallmann syndrome? </span></span></p>",
      "unique_key": "Q6298291",
      "question_audio": null,
      "question_video": null,
      "map_id": 12043,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Can be inherited as an autosomal dominant or autosomal recessive disorder</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defects in the ability to smell (hyposmia or anosmia) and primary amenorrhoea is known as Kallmann syndrome. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is syndrome can be inherited as an X-linked, autosomal dominant, or autosomal recessive disorder </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kallmann patients have a normal complement of GnRH neurons, however, these neurons fail to migrate and instead remain near the nasal epithelium </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As a result, locally secreted GnRH is unable to stimulate gonadotrophs in the anterior pituitary gland to release LH and FSH. In turn, marked decreases in ovarian estrogen production result in absence of breast development and menstrual cycles.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kallmann syndrome is also associated with midline facial anomalies such as cleft palate, unilateral renal agenesis, cerebellar ataxia, epilepsy, neurosensory hearing loss, and synkinesis (mirror movements of the hands) </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There will be hypogonadotropic hypogonadism</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at each option:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>A.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gonadotropin-Releasing Hormone (GnRH) Neurons Fail to Develop</strong>: This statement is incorrect as in Kallmann syndrome.&nbsp; GnRH neurons fail to migrate properly during embryonic development, leading to a deficiency in GnRH. This deficiency impairs the normal function of the hypothalamic-pituitary-gonadal axis, causing hypogonadotropic hypogonadism.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>It is a condition that leads to Hypergonadotropic Hypogonadism</strong>: Incorrect. Kallmann syndrome leads to hypogonadotropic hypogonadism. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Intact Sense of Smell Differentiates it from Other Similar Conditions</strong>: Incorrect. In Kallmann syndrome, the sense of smell is typically impaired (anosmia or hyposmia). This feature distinguishes it from other forms of hypogonadotropic hypogonadism where the sense of smell is intact.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Can be Inherited as an Autosomal Dominant or Autosomal Recessive Disorder</strong>: Kallmann syndrome can be inherited in multiple patterns, including autosomal dominant, autosomal recessive, and X-linked forms. The genetic heterogeneity of this condition allows for different inheritance patterns.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Kallmann syndrome is characterized by hypogonadotropic hypogonadism and an impaired sense of smell (anosmia or hyposmia). It can be inherited in an autosomal dominant, autosomal recessive, or X-linked pattern. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Speroff&rsquo;s 9<sup>th</sup> edition chapter 10, amenorrhea</span></span></strong></span></span></p>",
      "correct_choice_id": 48323,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12092,
      "choices": [
        {
          "id": 48332,
          "text": "<p><span style=\"font-size:16px;\">Serum&nbsp;</span><span style=\"font-size:12.0pt;\">Luteinizing hormone (LH)</span></p>"
        },
        {
          "id": 48333,
          "text": "<p><span style=\"font-size:16px;\">Serum&nbsp;</span><span style=\"font-size:12.0pt;\">Follicle-stimulating hormone (FSH)</span></p>"
        },
        {
          "id": 48334,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine Human chorionic gonadotropin (hCG)</span></p>"
        },
        {
          "id": 48335,
          "text": "<p><span style=\"font-size:16px;\">Serum&nbsp;</span><span style=\"font-size:12.0pt;\">Thyroid-stimulating hormone (TSH)</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 15-year-old with primary amenorrhea and Tanner stage V breast development presents for evaluation.&nbsp; Assessing levels for which of the following is the appropriate next step in her evaluation?</span></p>",
      "unique_key": "Q5139838",
      "question_audio": null,
      "question_video": null,
      "map_id": 12046,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. C. Urine Human chorionic gonadotropin (hCG)</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><span style=\"font-size:16px;\">As secondary sexual characters are present, the ovaries are functional</span></li><li><span style=\"background-color:transparent;font-size:16px;\">Although this is labeled primary amenorrhea, ovulation may occur before the first recognized menstruation — making pregnancy possible.</span></li><li><span style=\"font-size:16px;\">The first thing that needs to be ruled out (even though she has primary amenorrhoea) in such a situation is pregnancy</span></li><li><span style=\"font-size:16px;\">Hence hCG is the next best step in her evaluation</span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Let us consider each option</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option&nbsp;A.</strong>&nbsp;<strong>Serum Luteinizing Hormone (LH)</strong>: LH is involved in the regulation of the menstrual cycle and ovulation. While it can be useful in evaluating amenorrhea, it is not the first test to consider in a sexually active adolescent with primary amenorrhea.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option&nbsp;B</strong>.&nbsp;<strong>Serum&nbsp;Follicle-Stimulating Hormone (FSH)</strong>: FSH stimulates the growth of ovarian follicles. High levels can indicate ovarian failure, while low levels can suggest a pituitary or hypothalamic problem. However, like LH, it's not the initial test in this context.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option&nbsp;C.</strong>&nbsp;<strong>Urine Human Chorionic Gonadotropin (hCG)</strong>: Correct. The first step in the evaluation of a sexually active adolescent with primary amenorrhea is to rule out pregnancy. An hCG test, which detects pregnancy, is the most appropriate initial test, even in the presence of primary amenorrhea.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option&nbsp;D</strong>.&nbsp;<strong>Serum&nbsp;Thyroid-Stimulating Hormone (TSH)</strong>: TSH regulates thyroid function, which can impact menstrual cycles. However, thyroid dysfunction is less likely the cause in a patient with primary amenorrhea and normal development of secondary sexual characteristics.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Educational Objective</strong>: In a sexually active adolescent with primary amenorrhea and normal secondary sexual development, the first step is to rule out pregnancy with an hCG test. Pregnancy is a common and potentially reversible cause of amenorrhea, and its confirmation or exclusion guides further evaluation and management</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ref:&nbsp;Speroff’s 9<sup>th</sup> edition chapter 10, amenorrhea</strong></span></p>",
      "correct_choice_id": 48334,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12095,
      "choices": [
        {
          "id": 48344,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PCOS</span></span></span></span></p>"
        },
        {
          "id": 48345,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometriosis</span></span></span></span></p>"
        },
        {
          "id": 48346,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperprolactinemia</span></span></span></span></p>"
        },
        {
          "id": 48347,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovarian androgen-producing tumour</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Of the following conditions, which is most likely associated with the following finding?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/picture8_hSUrKHc.jpg\" style=\"height:365px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q2351493",
      "question_audio": null,
      "question_video": null,
      "map_id": 12047,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Ovarian androgen-producing tumour</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is an image showing clitoromegaly (Clitoris &gt; 1 cm)</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a sign of virilization</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical Features of Virilization are</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Acne </span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Androgenic alopecia </span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hirsutism </span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased breast size </span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amenorrhea </span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deepening of the voice </span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clitoromegaly </span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased muscle mass</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Virilization reflects higher androgen levels and should prompt investigation for an androgen-producing tumour of the ovary or adrenal gland</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us explore each option:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>A.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>PCOS (Polycystic Ovary Syndrome)</strong>: PCOS is characterized by a combination of symptoms like irregular menstrual cycles, polycystic ovaries, and signs of hyperandrogenism (e.g., hirsutism, acne). </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Endometriosis</strong>: Endometriosis involves the growth of endometrial tissue outside the uterus, causing pelvic pain, especially during menstruation, and may lead to infertility. It is not typically associated with findings indicative of an acute androgen increase.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hyperprolactinemia</strong>: Hyperprolactinemia can lead to symptoms like galactorrhea (milk production), amenorrhea, and infertility. It doesn&rsquo;t generally produce findings suggestive of excessive androgen production.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Ovarian Androgen-Producing Tumour</strong>: Correct. Ovarian androgen-producing tumors, such as Sertoli-Leydig cell tumors, can cause significantly elevated levels of androgens, leading to symptoms like hirsutism, virilization, and menstrual irregularities. This would be consistent with a finding indicative of high androgen levels.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Ovarian androgen-producing tumors can lead to markedly elevated androgen levels, resulting in signs of virilization and hirsutism. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 420, Williams Gynecology 3<sup>rd</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 48347,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}